GlassScriptPhysician profile
Joel Joseph
NPI 1013400548
$1,801.93
in general payments reported to CMS, 2019-2025
11 companies · $372 in 2025
The $372 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $182 · 2024: $1,249 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000 · Travel and Lodging: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,000.42 |
| Travel and Lodging | $801.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wilson Cook Medical Incorporated | $731.28 | 2024 | Hemospray |
| Abbvie INC. | $392.83 | 2023-2025 | |
| Cook Medical LLC | $220.14 | 2024 | Hemospray, Fusion |
| Madrigal Pharmaceuticals | $190.10 | 2025 | Rezdiffra |
| Medtronic, INC. | $100.57 | 2024 | Barrx, Gi Genius |
| Regeneron Healthcare Solutions, INC. | $50.51 | 2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $37.52 | 2025 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $25.46 | 2025 | Entyvio |
| Janssen Biotech, INC. | $19.80 | 2025 | Simponi, Simponi Aria, Tremfya |
| Qol Medical, LLC | $18.59 | 2025 | Sucraid |
| Olympus America INC. | $15.13 | 2023 | Endoclot Phs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.